Skip to product information
1 of 3

ZARC

Neo Sealer Putty MTA (bioceramic in syringe - by Avalon)

Neo Sealer Putty MTA (bioceramic in syringe - by Avalon)

Ready-to-use MTA bioceramic in a syringe, no mixing required.
Ideal for pulp capping, pulpotomy, apexification, and root-end filling. 47% active product, tantalum-enhanced radiopacity.
Available in 0.5g or 1.2g syringes.

Regular price 151.00 €
Regular price Sale price 151.00 €
Sale Sold out
Tax included.
Compatible with shipping in reusable packaging
View full details

Product information

By Stéphane Simon

Material in the form of "putty" filling from the Bioceramic family based on Mineral Trioxide Aggregate (MTA).

This is a ready-to-use material, packaged in a syringe. There is no need to mix.

Radiopacity is obtained by adding Tantalum and not Zirconium Oxide. The very high radiopacity of Tantalum allows for very good radiopacity while retaining a maximum of active product (**47% active product,** 44% tantalum and 9% stabilizers) which makes it one of the most concentrated products in active product available on the market.

We recommend this material for the following indications:

- Retro obturation in surgery
- Sealing of floor or side perforations
- Apexification treatment
- Pulp capping and cameral pulpotomy

Technical description of the product

Description

The most concentrated MTA bioceramic on the market, ready to use

Neo Sealer Putty is the "putty" version of Neo MTA, marketed for over 20 years by the American company Avalon and distributed by ZARC since 2022. It is a ready-to-use material packaged in a syringe — no mixing is required. Simply take the desired amount from the syringe with a spatula, then shape it between your fingers to adapt it to the indication.

47% active product — the most concentrated on the market Radio-opacity is achieved by adding Tantalum, not Zirconium Oxide. For the same quantity, Tantalum is 20% more radio-opaque than Zirconium Oxide, which allows for a maximum of active product in the formulation: 47% active product, 44% Tantalum, and 9% stabilizers.

Clinical Indications

  • Direct and indirect pulp capping
  • Cervical pulpotomy
  • Apexification
  • Treatment of floor or lateral perforations
  • Retrograde filling in endodontic surgery

Adjustable Consistency If necessary, the consistency can be adjusted by adding a small amount of NeoMTA2 powder to achieve a firmer texture.

Made in America Manufactured in the USA by Avalon Biomed — distributed by ZARC (Spain).

Technical Description

Feature Value
Family MTA Bioceramic
Presentation Ready-to-use putty in a syringe
Radio-opacifier Tantalum (20% more radio-opaque than ZrO2)
Composition 47% active product / 44% Tantalum / 9% stabilizers
Packaging 0.5g or 1.2g syringe
Mixing None — ready to use
Manufacturing USA (Avalon Biomed) – distributed by ZARC (Spain)